Dual regulation of Fbw7 function and oncogenic transformation by Usp28

Cell Reports

Volumn 9, Issue 3, 2014, Pages 1099-1109

  Schülein Völk, Christina ^a   Wolf, Elmar ^a   Zhu, Jing ^b   Xu, Wenshan ^b   Taranets, Lyudmyla ^b   Hellmann, Andreas ^b   Jänicke, Laura A ^a   Diefenbacher, Markus E ^c   Behrens, Axel ^c   Eilers, Martin ^a,b   Popov, Nikita ^a,b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c THE FRANCIS CRICK INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEUBIQUITINASE; PROTEIN FBW7; PROTEIN USP28; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; F BOX PROTEIN; FBXW7 PROTEIN, HUMAN; FBXW7 PROTEIN, MOUSE; UBIQUITIN THIOLESTERASE; USP28 PROTEIN, HUMAN; USP28 PROTEIN, MOUSE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENZYMATIC DEGRADATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME STABILITY; ENZYME SUBSTRATE; FIBROBLAST; GENETIC REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN METABOLISM; TRANSCRIPTION REGULATION; UBIQUITINATION; ALLELE; ANIMAL; ANTIBODY SPECIFICITY; BIOCATALYSIS; BIOLOGICAL MODEL; CELL TRANSFORMATION; ENZYME SPECIFICITY; GENE DELETION; GENETIC TRANSCRIPTION; HELA CELL LINE; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PROTEIN STABILITY;

MUS;

ALLELES; ANIMALS; BIOCATALYSIS; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; F-BOX PROTEINS; GENE DELETION; HELA CELLS; HUMANS; MICE, KNOCKOUT; MODELS, BIOLOGICAL; ORGAN SPECIFICITY; PROTEIN STABILITY; PROTEOLYSIS; SUBSTRATE SPECIFICITY; TRANSCRIPTION, GENETIC; UBIQUITIN THIOLESTERASE; UBIQUITIN-PROTEIN LIGASES;

EID: 84919710063     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.09.057     Document Type: Article

References (36)

1. Ahmed, N., Zeng, M., Sinha, I., Polin, L., Wei, W.-Z., Rathinam, C., Flavell, R., Massoumi, R., and Venuprasad, K. (2011). The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation. Nat. Immunol. 12, 1176-1183.
2. Akhoondi, S., Sun, D., von der Lehr, N., Apostolidou, S., Klotz, K., Maljukova, A., Cepeda, D., Fiegl, H., Dafou, D., Marth, C., et al. (2007). FBXW7/ hCDC4 is a general tumor suppressor in human cancer. Cancer Res. 67, 9006-9012.
3. Bassermann, F., Frescas, D., Guardavaccaro, D., Busino, L., Peschiaroli, A., and Pagano, M. (2008). The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA damage-response checkpoint. Cell 134, 256-267.
4. Bengoechea-Alonso, M.T., and Ericsson, J. (2010). The ubiquitin ligase Fbxw7 controls adipocyte differentiation by targeting C/EBPalpha for degradation. Proc. Natl. Acad. Sci. USA 107, 11817-11822.
5. Cerami, E., Gao, J., Dogrusoz, U., Gross, B.E., Sumer, S.O., Aksoy, B.A., Jacobsen, A., Byrne, C.J., Heuer, M.L., Larsson, E., et al. (2012). The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2, 401-404.
6. Chen, B.B., Glasser, J.R., Coon, T.A., Zou, C., Miller, H.L., Fenton, M., McDyer, J.F., Boyiadzis, M., and Mallampalli, R.K. (2012). F-box protein FBXL2 targets cyclin D2 for ubiquitination and degradation to inhibit leukemic cell proliferation. Blood 119, 3132-3141.
7. de Vries, W.N., Binns, L.T., Fancher, K.S., Dean, J., Moore, R., Kemler, R., and Knowles, B.B. (2000). Expression of Cre recombinase in mouse oocytes: a means to study maternal effect genes. Genesis 26, 110-112.
8. Diefenbacher, M.E., Popov, N., Blake, S.M., Schülein-Völk, C., Nye, E., Spencer-Dene, B., Jaenicke, L.A., Eilers, M., and Behrens, A. (2014). The deubiquitinase USP28 controls intestinal homeostasis and promotes colorectal cancer. J. Clin. Invest. 124, 3407-3418.
9. Durgan, J., and Parker, P.J. (2010). Regulation of the tumour suppressor Fbw7α by PKC-dependent phosphorylation and cancer-associated mutations. Biochem. J. 432, 77-87.
10. Flügel, D., Görlach, A., and Kietzmann, T. (2012). GSK-3β regulates cell growth, migration, and angiogenesis via Fbw7 and USP28-dependent degradation of HIF-1α. Blood 119, 1292-1301.
11. Forbes, S.A., Bhamra, G., Bamford, S., Dawson, E., Kok, C., Clements, J., Menzies, A., Teague, J.W., Futreal, P.A., and Stratton, M.R. (2008). The catalogue of somatic mutations in cancer (COSMIC). Curr. Protoc. Hum. Genet. 10, 10.11.
12. Galli, F., Rossi, M., D'Alessandra, Y., De Simone, M., Lopardo, T., Haupt, Y., Alsheich-Bartok, O., Anzi, S., Shaulian, E., Calabrò, V., et al. (2010). MDM2 and Fbw7 cooperate to induce p63 protein degradation following DNA damage and cell differentiation. J. Cell Sci. 123, 2423-2433.
13. Hoeller, D., and Dikic, I. (2009). Targeting the ubiquitin system in cancer therapy. Nature 458, 438-444.
14. Hu, M., Gu, L., Li, M., Jeffrey, P.D., Gu, W., and Shi, Y. (2006). Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53-MDM2 pathway. PLoS Biol. 4, e27.
15. Huang, X., Summers, M.K., Pham, V., Lill, J.R., Liu, J., Lee, G., Kirkpatrick, D.S., Jackson, P.K., Fang, G., and Dixit, V.M. (2011). Deubiquitinase USP37 is activated by CDK2 to antagonize APC(CDH1) and promote S phase entry. Mol. Cell 42, 511-523.
16. Keusekotten, K., Elliott, P.R., Glockner, L., Fiil, B.K., Damgaard, R.B., Kulathu, Y., Wauer, T., Hospenthal, M.K., Gyrd-Hansen, M., Krappmann, D., et al. (2013). OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin. Cell 153, 1312-1326.
17. Knobel, P.A., Belotserkovskaya, R., Galanty, Y., Schmidt, C.K., Jackson, S.P., and Stracker, T.H. (2014). USP28 is recruited to sites of DNA damage by the tandem BRCT domains of 53BP1 but plays a minor role in double-strand break metabolism. Mol. Cell. Biol. 34, 2062-2074.
18. Lachmann, A., Xu, H., Krishnan, J., Berger, S.I., Mazloom, A.R., and Ma'ayan, A. (2010). ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics 26, 2438-2444.
19. Li, M., Brooks, C.L., Kon, N., and Gu, W. (2004). A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol. Cell 13, 879-886.
20. Li, L., Anderson, S., Secombe, J., and Eisenman, R.N. (2013). The Drosophila ubiquitin-specific protease Puffyeye regulates dMyc-mediated growth. Development 140, 4776-4787.
21. Min, S.-H., Lau, A.W., Lee, T.H., Inuzuka, H., Wei, S., Huang, P., Shaik, S., Lee, D.Y., Finn, G., Balastik, M., et al. (2012). Negative regulation of the stability and tumor suppressor function of Fbw7 by the Pin1 prolyl isomerase. Mol. Cell 46, 771-783.
22. Mo, J.-S., Ann, E.-J., Yoon, J.-H., Jung, J., Choi, Y.-H., Kim, H.-Y., Ahn, J.-S., Kim, S.-M., Kim, M.-Y., Hong, J.-A., et al. (2011). Serum-and glucocorticoidinducible kinase 1 (SGK1) controls Notch1 signaling by downregulation of protein stability through Fbw7 ubiquitin ligase. J. Cell Sci. 124, 100-112.
23. Penn, L.J., Brooks, M.W., Laufer, E.M., and Land, H. (1990). Negative autoregulation of c-myc transcription. EMBO J. 9, 1113-1121.
24. Pérez-Benavente, B., García, J.L., Rodríguez, M.S., Pineda-Lucena, A., Piechaczyk, M., Font de Mora, J., and Farràs, R. (2013). GSK3-SCF(FBXW7) targets JunB for degradation in G2 to preserve chromatid cohesion before anaphase. Oncogene 32, 2189-2199.
25. Popov, N., Wanzel, M., Madiredjo, M., Zhang, D., Beijersbergen, R., Bernards, R., Moll, R., Elledge, S.J., and Eilers, M. (2007a). The ubiquitin-specific protease USP28 is required for MYC stability. Nat. Cell Biol. 9, 765-774.
26. Popov, N., Herold, S., Llamazares, M., Schülein, C., and Eilers, M. (2007b). Fbw7 and Usp28 regulate myc protein stability in response to DNA damage. Cell Cycle 6, 2327-2331.
27. Popov, N., Schülein, C., Jaenicke, L.A., and Eilers, M. (2010). Ubiquitylation of the amino terminus of Myc by SCF(b-TrCP) antagonizes SCF(Fbw7)-mediated turnover. Nat. Cell Biol. 12, 973-981.
28. Schülein, C., Eilers, M., and Popov, N. (2011). PI3K-dependent phosphorylation of Fbw7 modulates substrate degradation and activity. FEBS Lett. 585, 2151-2157.
29. Sears, R., Nuckolls, F., Haura, E., Taya, Y., Tamai, K., and Nevins, J.R. (2000). Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev. 14, 2501-2514.
30. Sherman, B.T., Huang, W., Tan, Q., Guo, Y., Bour, S., Liu, D., Stephens, R., Baseler, M.W., Lane, H.C., and Lempicki, R.A. (2007). DAVID Knowledgebase: a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis. BMC Bioinformatics 8, 426.
31. Tsunematsu, R., Nakayama, K., Oike, Y., Nishiyama, M., Ishida, N., Hatakeyama, S., Bessho, Y., Kageyama, R., Suda, T., and Nakayama, K.I. (2004). Mouse Fbw7/Sel-10/Cdc4 is required for notch degradation during vascular development. J. Biol. Chem. 279, 9417-9423.
32. Vaites, L.P., Lee, E.K., Lian, Z., Barbash, O., Roy, D., Wasik, M., Klein-Szanto, A.J.P., Rustgi, A.K., and Diehl, J.A. (2011). The Fbx4 tumor suppressor regulates cyclin D1 accumulation and prevents neoplastic transformation. Mol. Cell. Biol. 31, 4513-4523.
33. Wang, Z., Inuzuka, H., Zhong, J., Wan, L., Fukushima, H., Sarkar, F.H., and Wei, W. (2012). Tumor suppressor functions of FBW7 in cancer development and progression. FEBS Lett. 586, 1409-1418.
34. Welcker, M., and Clurman, B.E. (2008). FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat. Rev. Cancer 8, 83-93.
35. Welcker, M., Larimore, E.A., Swanger, J., Bengoechea-Alonso, M.T., Grim, J.E., Ericsson, J., Zheng, N., and Clurman, B.E. (2013). Fbw7 dimerization determines the specificity and robustness of substrate degradation. Genes Dev. 27, 2531-2536.
36. Zhang, D., Zaugg, K., Mak, T.W., and Elledge, S.J. (2006). A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response. Cell 126, 529-542.